KLTO Kacepetan wutah bathi saben saham ing taun lumaku anewmeds.com

Klotho Neurosciences Inc (KLTO) is implementing AI protein modeling to accelerate the discovery of dementia drugs while researching the anti-aging properties of the Klotho protein. The annual EPS growth rate reflects the result of this synergy, with the value recorded at 0.00. A stable staff of Alzheimer's and Parkinson's disease experts provides the foundation for the successful launch of new clinical trials.
Rincian metrik komprehensif lan analitis anewmeds.com (KLTO)

Klotho Neurosciences Inc (KLTO) specializes in developing innovative treatments for age-related and neurodegenerative pathologies. The eps_yy_co metric measures the year-over-year dynamics of earnings per share, reflecting the efficiency of capital management. For companies in the preclinical research stage, this indicator reveals the impact of investment inflows on financial results. A positive trend signals an increase in the asset's fundamental value. By analyzing the rate of change in earnings per share over 12 months, an investor can assess the business's competitiveness.